UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008645
Receipt number R000009970
Scientific Title Safety evaluation of a self-assembling peptide gel for the application as a hemostatic material in dentistry
Date of disclosure of the study information 2012/08/28
Last modified on 2016/12/27 10:54:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Safety evaluation of a self-assembling peptide gel for the application as a hemostatic material in dentistry

Acronym

Safety evaluation of a self-assembling peptide gel in dentistry

Scientific Title

Safety evaluation of a self-assembling peptide gel for the application as a hemostatic material in dentistry

Scientific Title:Acronym

Safety evaluation of a self-assembling peptide gel in dentistry

Region

Japan


Condition

Condition

Gingivitis

Classification by specialty

Dental medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to evaluate the safety of non-animal derived self-assembling peptide gel, PanaceaGel for the application as a hemostatic material.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Phase I


Assessment

Primary outcomes

Safety

Key secondary outcomes

Hemostatic effect


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

3

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

Test product is put on marginl gingiva.

Interventions/Control_2

Placebo product is put on marginal gingiva.

Interventions/Control_3

Conventional product is put on marginal gingiva.

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

healthy dentist
Person who has 3 teeth with 4-6mm periodontal pockets and bleeding

Key exclusion criteria

excluding "key inclusion criteria"

Target sample size

15


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shogo Takashiba

Organization

Okayama University

Division name

Department of Pathophysiology-Periodontal Science, Graduate Schoolof Medicine, Dentistry and Pharmaceutical Sciences

Zip code


Address

2-5-1 Shikata-cho, Kita-ku, Okayama, Japan

TEL

086-235-6675

Email

stakashi@cc.okayama-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Shogo Takashiba

Organization

Okayama University

Division name

Department of Pathophysiology-Periodontal Science, Graduate Schoolof Medicine, Dentistry and Pharmac

Zip code


Address

2-5-1 Shikata-cho, Kita-ku, Okayama, Japan

TEL

086-235-6675

Homepage URL


Email

stakashi@cc.okayama-u.ac.jp


Sponsor or person

Institute

Okayama Univesity

Institute

Department

Personal name



Funding Source

Organization

Okayama University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

岡山大学病院


Other administrative information

Date of disclosure of the study information

2012 Year 08 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 08 Month 28 Day

Date of IRB


Anticipated trial start date

2012 Year 08 Month 28 Day

Last follow-up date

2012 Year 09 Month 30 Day

Date of closure to data entry

2012 Year 10 Month 31 Day

Date trial data considered complete

2012 Year 12 Month 28 Day

Date analysis concluded

2013 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2012 Year 08 Month 08 Day

Last modified on

2016 Year 12 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009970


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name